门诊分层防治对短暂性脑缺血发作患者预后的影响

来源 :中国医疗前沿 | 被引量 : 0次 | 上传用户:myrost
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨用ABCD2量表对中风防治门诊短暂性脑缺血发作(TIA)患者进行危险分层并进行强化治疗对90d脑梗死发生的影响。方法依据ABCD2量表评分将患者分为三组,均在中风防治门诊接受相同标准的治疗,观察TIA患者90d内脑梗死的发生率。结果共有653例患者达到了本研究的入组标准,其中639例完成了90d的随访。低危、中危以及高危组的患者分别占32.7%、47.7%和19.6%。所有患者90d内总的脑梗死发生率为2.5%,而使用ABCD2量表预测的结果为9.2%。结论依据ABCD2量表评分对中风防治门诊TIA患者进行分层并及时治疗,可以降低不同危险分层TIA患者90d内脑梗死的发生率。 Objective To investigate the effect of stratified risk stratification and intensive treatment on the incidence of 90-day cerebral infarction in stroke prevention and treatment outpatient transient ischemic attack (TIA) with ABCD2 scale. Methods The patients were divided into three groups according to the ABCD2 scale score. All patients underwent the same standard treatment in stroke prevention and treatment clinics. The incidence of cerebral infarction within 90 days of TIA was observed. Results A total of 653 patients met the inclusion criteria for this study, of whom 639 completed the 90-day follow-up. Patients in low risk, intermediate risk and high risk groups accounted for 32.7%, 47.7% and 19.6% respectively. The overall incidence of cerebral infarction within 90 days was 2.5% in all patients, compared with 9.2% for the ABCD2 scale. Conclusions The stratification and timely treatment of TIA patients with stroke prevention and treatment clinics according to the ABCD2 scale can reduce the incidence of cerebral infarction within 90 days in patients with different risk stratification TIA.
其他文献
目的观察替吉奥(S-1)联合奥沙利铂(oxaliplatin,L-OHP)方案治疗晚期胃癌的近期疗效及毒性反应。方法 23例均经病理组织学确诊为晚期胃腺癌,且手术不可切除或术后复发、转移胃
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥
期刊
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥
期刊
目的观察纳络酮联合重组组织型纤溶酶原激活剂(rt-PA)治疗急性脑梗死的临床疗效,并评定其安全性。方法将我院2012年1月-2013年2月间收治的118例急性脑梗死患者随机分为两组各
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥
期刊